KPIs & Operating Metrics(New)
Growth Metrics

Chemed (CHE) Net Income towards Common Stockholders (2016 - 2026)

Chemed filings provide 18 years of Net Income towards Common Stockholders readings, the most recent being $66.3 million for Q1 2026.

  • For the quarter ending Q1 2026, Net Income towards Common Stockholders fell 7.6% year-over-year to $66.3 million, compared with a TTM value of $349.9 million through Mar 2026, up 13.34%, and an annual FY2025 reading of $355.4 million, up 17.67% over the prior year.
  • Net Income towards Common Stockholders hit $66.3 million in Q1 2026 for Chemed, down from $166.9 million in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was $166.9 million in Q4 2025, with the low at $52.5 million in Q2 2025.
  • Median Net Income towards Common Stockholders over the past 5 years was $66.3 million (2026), compared with a mean of $73.4 million.
  • The largest YoY upside for Net Income towards Common Stockholders was 84.77% in 2025 against a maximum downside of 25.95% in 2025.
  • Year by year, Net Income towards Common Stockholders stood at $62.1 million in 2022, then skyrocketed by 49.02% to $92.6 million in 2023, then fell by 2.44% to $90.3 million in 2024, then surged by 84.77% to $166.9 million in 2025, then tumbled by 60.27% to $66.3 million in 2026.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods came in at $66.3 million, $166.9 million, and $64.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.